Profound Medical Corp. (PROF)
NASDAQ: PROF · Real-Time Price · USD
7.25
-0.03 (-0.41%)
Dec 20, 2024, 4:00 PM EST - Market closed

Profound Medical Revenue

Profound Medical had revenue of $2.83M in the quarter ending September 30, 2024, with 63.89% growth. This brings the company's revenue in the last twelve months to $8.98M, up 39.35% year-over-year. In the year 2023, Profound Medical had annual revenue of $7.20M with 7.75% growth.

Revenue (ttm)
$8.98M
Revenue Growth
+39.35%
P/S Ratio
n/a
Revenue / Employee
$68,580
Employees
131
Market Cap
215.83M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20237.20M518.00K7.75%
Dec 31, 20226.68M-192.00K-2.79%
Dec 31, 20216.87M-431.00K-5.90%
Dec 31, 20207.30M3.13M74.99%
Dec 31, 20194.17M1.57M60.40%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
biote 193.06M
LifeMD 193.06M
SOPHiA GENETICS 64.49M
Zentalis Pharmaceuticals 40.56M
Inhibrx Biosciences 1.57M
Cardiff Oncology 688.00K
Inhibikase Therapeutics 1.00
Revenue Rankings